Ambient Clinical Analytics Announces the Close of a $5.4M Series A Funding Round to Drive Growth in its Clinical Decision Support and Control Tower Software Platform
ROCHESTER, MN – Ambient Clinical Analytics announces today that it has completed a $5.4M Series A Funding Round led by Waterline Ventures and Bluestem Capital, with participation from Social Capital. Founded by a Mayo Clinic academic clinical team and seasoned technology entrepreneurs, Ambient Clinical Analytics’ software enhances the way critical care providers operate. The company sells clinical decision support and alerting tools to hospitals which result in reduced errors, lower health care costs, and better patient outcomes.
“With FDA Class II Clearance, and the collaboration with Philips on AWARE® for their IntelliSpace Console Critical Care product, Ambient Clinical is in a great positon to grow the market for our Mayo Clinic developed analytics based clinical decision support tools,” explains Al Berning, CEO, Ambient Clinical Analytics. “We’re excited to be starting a partnership with Waterline Ventures and Bluestem Capital, both with extensive experience in Health IT. With the Series A funding, Ambient Clinical is in the process of expanding its sales, marketing and product development activities.”
“We are excited to be working with a highly experienced team at Ambient,” said Robbie Greenglass, Managing Director, Waterline Ventures. “They have positioned the company to be extremely impactful in changing the way emergency departments and intensive care units visualize important information about patients in real time. Ambient pulls data from the EMR and displays it in intuitive, easy to read ways, so that clinicians can focus on patients’ needs.”
“Ambient Clinical Analytics’ clinical decision support software solves a key problem for all critical and emergency care units,” said Tyler Stowater, Partner and Vice President, Bluestem. “Mayo Clinics’ extensive research and Ambient Clinicals ability to support FDA Class II clearance and launch products to the market, is a powerful combination.”
Ambient Clinical uses licensed Mayo Clinic technologies, which include over 1,000 rules and algorithms, to give critical care providers real-time access to vital process-of-care information and analytics at the point-of-care, as well as from a central Clinical Control Tower. Bedside based alerts for conditions like Sepsis allow physicians and medical personnel to spend more time with patients instead of reviewing information. Ambient Clinicals’ products are designed to support a hospital’s Lean Quality and Six Sigma initiatives. Ambient Clinical has achieved FDA Class II Clearance for the AWAR and Sepsis DART software platform.
Sepsis DART uses customer-defined sepsis detection and support rules to indicate that sepsis may be present or developing. With algorithms created in conjunction with Mayo Clinic clinicians to comply with CMS requirements, DART alerts caregivers that sepsis may be present or developing and monitors treatment progression during the critical first six hours of care. The solution also supports quality and CMS reporting requirements.
Mayo Clinic YES Board® is a multi-patient management tool that provides real-time situational awareness for Emergency Departments and hospital Pediatric departments. The solution provides real-time patient information in an at-a-glance overview format that ensures care teams have ready access to clinically relevant information.
To learn more about Ambient Clinicals’ transformational products visit: www.ambientclinical.com
Prior to the Series A funding round, Ambient Clinical received $2.9 million in seed funding from Social Capital, Mayo Clinic, Rock Health, Rochester Area Economic Development Inc., Southern Minnesota Initiative Foundation, Gopher Angels and angel investors. The seed funding was converted to Series A preferred stock at the closing.
“With FDA Class II Clearance, and the collaboration with Philips on AWARE® for their IntelliSpace Console Critical Care product, Ambient Clinical is in a great positon to grow the market for our Mayo Clinic developed analytics based clinical decision support tools,” explains Al Berning, CEO, Ambient Clinical Analytics. “We’re excited to be starting a partnership with Waterline Ventures and Bluestem Capital, both with extensive experience in Health IT. With the Series A funding, Ambient Clinical is in the process of expanding its sales, marketing and product development activities.”
“We are excited to be working with a highly experienced team at Ambient,” said Robbie Greenglass, Managing Director, Waterline Ventures. “They have positioned the company to be extremely impactful in changing the way emergency departments and intensive care units visualize important information about patients in real time. Ambient pulls data from the EMR and displays it in intuitive, easy to read ways, so that clinicians can focus on patients’ needs.”
“Ambient Clinical Analytics’ clinical decision support software solves a key problem for all critical and emergency care units,” said Tyler Stowater, Partner and Vice President, Bluestem. “Mayo Clinics’ extensive research and Ambient Clinicals ability to support FDA Class II clearance and launch products to the market, is a powerful combination.”
Ambient Clinical uses licensed Mayo Clinic technologies, which include over 1,000 rules and algorithms, to give critical care providers real-time access to vital process-of-care information and analytics at the point-of-care, as well as from a central Clinical Control Tower. Bedside based alerts for conditions like Sepsis allow physicians and medical personnel to spend more time with patients instead of reviewing information. Ambient Clinicals’ products are designed to support a hospital’s Lean Quality and Six Sigma initiatives. Ambient Clinical has achieved FDA Class II Clearance for the AWAR and Sepsis DART software platform.
Ambient Clinical Analytics’ core offerings include:
AWARE is a clinical software tool that reduces information overload by using analytics to filter relevant patient data and provide timely, actionable information. Created by clinicians for clinicians, AWARE clearly and concisely presents actionable information to all care team members to improve patient outcomes, reduce the cost of care, and support best-care practices for ICUs and other critical care areas.Sepsis DART uses customer-defined sepsis detection and support rules to indicate that sepsis may be present or developing. With algorithms created in conjunction with Mayo Clinic clinicians to comply with CMS requirements, DART alerts caregivers that sepsis may be present or developing and monitors treatment progression during the critical first six hours of care. The solution also supports quality and CMS reporting requirements.
Mayo Clinic YES Board® is a multi-patient management tool that provides real-time situational awareness for Emergency Departments and hospital Pediatric departments. The solution provides real-time patient information in an at-a-glance overview format that ensures care teams have ready access to clinically relevant information.
To learn more about Ambient Clinicals’ transformational products visit: www.ambientclinical.com
Prior to the Series A funding round, Ambient Clinical received $2.9 million in seed funding from Social Capital, Mayo Clinic, Rock Health, Rochester Area Economic Development Inc., Southern Minnesota Initiative Foundation, Gopher Angels and angel investors. The seed funding was converted to Series A preferred stock at the closing.